var data={"title":"Rosacea: Pathogenesis, clinical features, and diagnosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Rosacea: Pathogenesis, clinical features, and diagnosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Mark V Dahl, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 04, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H394012116\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rosacea is a common, chronic disorder that can present with a variety of cutaneous or ocular manifestations. Skin involvement primarily affects the central face, with findings such as persistent centrofacial redness, papules, pustules, flushing, telangiectasia, and phymatous skin changes (eg, rhinophyma). Ocular involvement may also occur, manifesting with lid margin telangiectases, conjunctival injection, ocular irritation, or other signs and symptoms. &#160;</p><p>The pathogenesis, clinical manifestations, and diagnosis of rosacea will be reviewed here. The treatment of rosacea is discussed separately. (See <a href=\"topic.htm?path=management-of-rosacea\" class=\"medical medical_review\">&quot;Management of rosacea&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H394012123\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rosacea is a common disorder that is most frequently observed in individuals with lightly pigmented skin (skin phototypes I and II (<a href=\"image.htm?imageKey=PC%2F60541\" class=\"graphic graphic_table graphicRef60541 \">table 1</a>)). People of Celtic and Northern European origin appear to have the greatest risk for this disorder [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The prevalence of rosacea is difficult to assess due to its variable clinical manifestations and the wide variety of skin disorders that exhibit similar clinical features (see <a href=\"#H394012195\" class=\"local\">'Differential diagnosis'</a> below). Estimates of the prevalence of rosacea in fair-skinned populations range from 1 to 10 percent [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/1,3,4\" class=\"abstract_t\">1,3,4</a>].</p><p>Rosacea occurs in people with greater skin pigmentation but is less frequently diagnosed in such populations (<a href=\"image.htm?imageKey=DERM%2F53889%7EDERM%2F63008\" class=\"graphic graphic_picture graphicRef53889 graphicRef63008 \">picture 1A-B</a>) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/5-10\" class=\"abstract_t\">5-10</a>]. It is unknown whether factors such as masking of facial redness by abundant skin pigment, protective effects of melanin against ultraviolet radiation (an exacerbating factor for rosacea), or genetic differences in susceptibility to rosacea contribute to the lower rate of diagnosis in people with dark skin.</p><p>Adults over the age of 30 are the primary age group affected by rosacea, and the disorder occurs more frequently in women than in men [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/1,11\" class=\"abstract_t\">1,11</a>]. Patients with phymatous skin changes are an exception; the vast majority of affected patients are adult males (<a href=\"image.htm?imageKey=DERM%2F61822\" class=\"graphic graphic_picture graphicRef61822 \">picture 2</a>). Rosacea occasionally occurs in adolescents. In this population, rosacea is often mistaken for acne vulgaris. Rarely, rosacea occurs in children. Children may exhibit all subtypes except phymatous changes, and symptoms may persist into adulthood [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/12-14\" class=\"abstract_t\">12-14</a>]. </p><p>Analyses of data from the Nurses' Health Study II suggest that obesity, a past smoking history, and increased alcohol consumption may be risk factors for rosacea in women [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/15-17\" class=\"abstract_t\">15-17</a>].</p><p class=\"headingAnchor\" id=\"H394012131\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathways that lead to the development of rosacea are not well understood [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/18,19\" class=\"abstract_t\">18,19</a>]. Proposed contributing factors include abnormalities in innate immunity, inflammatory reactions to cutaneous microorganisms, ultraviolet damage, and vascular dysfunction. </p><p class=\"headingAnchor\" id=\"H433190\"><span class=\"h2\">Immune dysfunction</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The innate immune system plays a key role in the cutaneous immune response to microorganisms and to insults such as ultraviolet radiation and physical or chemical trauma [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. Dysfunction of the innate immune system may contribute to the development of chronic inflammation and vascular abnormalities in rosacea.</p><p>The process through which aberrations of the innate immune system may contribute to rosacea may involve the production of abnormal cathelicidin peptides that have vasoactive and inflammatory properties [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. Increased levels of abnormal cathelicidin and kallikrein 5 (a processing enzyme for cathelicidin that is also known as stratum corneum tryptic enzyme) have been detected in skin from patients with rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>]. </p><p>The subsequent discovery that toll-like receptor 2, a component of the innate immune system that interacts with environmental stimuli, can stimulate release of kallikrein 5 from epidermal keratinocytes offers a potential explanation for a link between environmental insults and cathelicidin-mediated abnormalities in rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/22\" class=\"abstract_t\">22</a>]. Moreover, a study in which the injection of mouse skin with cathelicidin peptides from patients with rosacea led to inflammation and vascular dilatation provides additional evidence to implicate cathelicidin as a pathogenic factor [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/21\" class=\"abstract_t\">21</a>].</p><p class=\"headingAnchor\" id=\"H433233\"><span class=\"h2\">Microorganisms</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Stimulation of inflammatory reactions by microbes in or on the skin has been proposed as an inciting factor for cutaneous inflammation in rosacea.</p><p class=\"headingAnchor\" id=\"H433276\"><span class=\"h3\">Demodex</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Demodex folliculorum</em> is a saprophytic mite that resides in sebaceous follicles. Although <em>Demodex</em> mites can be found on normal skin in almost all adults, increased density of <em>Demodex</em> mites in patients with rosacea has been reported in multiple studies [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/23-26\" class=\"abstract_t\">23-26</a>]. In a meta-analysis of case-control studies, a statistically significant association between <em>Demodex</em> infestation and rosacea was detected, with the degree of infestation being more important than the rate of infestation [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/23\" class=\"abstract_t\">23</a>]. The role of <em>Demodex</em> mites as an inciting factor for rosacea remains uncertain.</p><p class=\"headingAnchor\" id=\"H433283\"><span class=\"h3\">Bacillus olenorium</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The knowledge that papulopustular rosacea improves with antibiotic therapy led to an in vitro study investigating <em>Bacillus oleronius</em>, a bacterium that was isolated from a single <em>Demodex</em> mite, as a potential cause of inflammation in rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/27\" class=\"abstract_t\">27</a>]. The study found that antigens from <em>B. oleronius </em>stimulated proliferation of peripheral blood mononuclear cells from 16 out of 22 patients with rosacea (73 percent) versus only 5 out of 17 patients without rosacea (29 percent). Additional studies are necessary to determine whether <em>B. oleronius</em> is a common colonizer of <em>Demodex</em> mites and whether the organism is involved in the pathogenesis of rosacea.</p><p class=\"headingAnchor\" id=\"H433290\"><span class=\"h3\">Helicobacter pylori</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A role for gastrointestinal <em>Helicobacter pylori</em> infection in rosacea is controversial. Data conflict on whether the prevalence of <em>H. pylori</em> infection is increased in patients with rosacea and reports of improvement in rosacea following antibiotic therapy for <em>H. pylori</em> infection may be attributable to antiinflammatory effects of the antibiotics used for treatment [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/28\" class=\"abstract_t\">28</a>]. A meta-analysis of 14 observational studies did not find a significant association between <em>H. pylori</em> infection and rosacea (odds ratio 1.68, 95% CI 1.00-2.84) nor an effect of <em>H. pylori</em> eradication therapy on rosacea symptomatic improvement (relative risk 1.28, 95% CI 0.98-1.67) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/29\" class=\"abstract_t\">29</a>].</p><p class=\"headingAnchor\" id=\"H433297\"><span class=\"h3\">Other</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Staphylococcus epidermidis</em> [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/30,31\" class=\"abstract_t\">30,31</a>], <em>Chlamydia pneumoniae</em> [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/32\" class=\"abstract_t\">32</a>], and small intestine bacteria [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/33\" class=\"abstract_t\">33</a>] have been linked to rosacea in a few studies. Additional investigation is necessary to determine whether any of these organisms have a significant impact on the development of rosacea.</p><p class=\"headingAnchor\" id=\"H433400\"><span class=\"h2\">Ultraviolet radiation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sun exposure is often cited as an exacerbating factor for rosacea, based upon the distribution of lesions on chronically sun-exposed skin, the detection of signs of solar elastosis on skin biopsy specimens, and the preferential appearance of the disorder in fair-skinned individuals. </p><p>Several theories on the mechanisms through which sun exposure could promote rosacea have been proposed. Ultraviolet B radiation has been shown to induce cutaneous angiogenesis in mice and can stimulate the secretion of vascular endothelial growth factor (VEGF)-2 and fibroblast growth factor (FGF)-2 from keratinocytes [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/34-36\" class=\"abstract_t\">34-36</a>]. Ultraviolet radiation may also stimulate production of damaging reactive oxygen species and may incite activation of the innate immune system [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>].</p><p>However, study data confirming an association between all phenotypes of rosacea and ultraviolet radiation are lacking [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. Fewer than one-third of patients with rosacea report exacerbations of symptoms with sunlight [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>], and a retrospective study in Korea of 168 patients with rosacea found that although high daily sun exposure correlated with increased severity of erythematotelangiectatic disease, it did not appear to have a significant effect on papulopustular, phymatous, or ocular rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/8\" class=\"abstract_t\">8</a>]. In addition, a study of 1000 adults in Ireland found no difference in the prevalence of papulopustular rosacea in subjects with high sun exposure versus those with lower sun exposure [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/4\" class=\"abstract_t\">4</a>]. Further studies are necessary to explore the impact of ultraviolet radiation on rosacea. </p><p>As noted above, extremes of temperature can be an exacerbating factor for rosacea. Thus, aside from ultraviolet light, infrared radiation (radiant heat) from sun exposure could contribute to exacerbations of rosacea. </p><p class=\"headingAnchor\" id=\"H433473\"><span class=\"h2\">Vascular hyperreactivity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Frequent and prolonged flushing is a common feature in rosacea and triggers of flushing (eg, spicy foods, alcohol, and extremes of temperature) have been anecdotally associated with worsening disease (see <a href=\"#H432985\" class=\"local\">'Exacerbating factors'</a> below). In addition, increased blood flow has been detected in the skin of some patients [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/10,38\" class=\"abstract_t\">10,38</a>]. These observations suggest a role for vascular hyperreactivity in the pathogenesis of this disorder [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"abstract_t\">20</a>]. Dysregulation of thermal mechanisms has also been proposed as a contributing factor to flushing in rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>].</p><p>The pathways that may lead to neurovascular dysregulation in rosacea are not well understood. One theory proposes that activation of transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 (receptors found on primary sensory neuron endings as well as keratinocytes) by triggers of rosacea (eg, extremes of temperature, spices, etc.) may stimulate the release of vasoactive peptides that exacerbate rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/39\" class=\"abstract_t\">39</a>].</p><p>Data conflict on whether rosacea is more common among people with migraines (another disorder proposed to involve vascular dysregulation) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/40-44\" class=\"abstract_t\">40-44</a>]. A large population-based case-control study found a slight increase in risk among women, but did not identify a statistically significant association between migraines and rosacea in men [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/40\" class=\"abstract_t\">40</a>].</p><p class=\"headingAnchor\" id=\"H433494\"><span class=\"h2\">Genetics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Individuals with a family history of rosacea may be more likely to develop the disorder [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/11\" class=\"abstract_t\">11</a>]. However, specific genetic factors associated with increased risk for rosacea have not been identified. Further studies are necessary to explore the impact of family history and genetic background on risk for rosacea.</p><p class=\"headingAnchor\" id=\"H811056387\"><span class=\"h1\">CLASSIFICATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In 2002, the National Rosacea Society assembled an expert committee to develop a standard classification system for rosacea. The committee established four distinct subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>]. Since then, increasing knowledge of the pathophysiology of rosacea has favored a view of rosacea as a consistent multivariate disease process with multiple clinical manifestations rather than distinct subtypes of disease [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>]. </p><p>Following recommendations from the Global ROSacea COnsensus (ROSCO) Panel supporting use of phenotype-based, rather than a subtype-based, approach to the diagnosis and classification of rosacea, the National Rosacea Society expert committee released an update supporting a similar approach [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/46,47\" class=\"abstract_t\">46,47</a>]. The phenotype-based approach describes the individual clinical features of rosacea and divides them into diagnostic, major, and secondary (or minor) <span class=\"nowrap\">features/phenotypes</span>. (See <a href=\"#H432867\" class=\"local\">'Clinical features'</a> below and <a href=\"#H2005836\" class=\"local\">'Diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H432867\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The various phenotypes of rosacea are listed below. Recognition of these features is essential for diagnosis. (See <a href=\"#H2005836\" class=\"local\">'Diagnosis'</a> below.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Centrofacial erythema</strong> &mdash; Patients with rosacea may exhibit chronic redness of the nose and medial cheeks (<a href=\"image.htm?imageKey=DERM%2F77020%7EDERM%2F56083\" class=\"graphic graphic_picture graphicRef77020 graphicRef56083 \">picture 3A-B</a>). Involvement of other sites, such as the ears, lateral face, neck, scalp, and chest, occasionally occurs [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Phymatous changes</strong> &mdash; Phymatous rosacea exhibits tissue hypertrophy manifesting as thickened skin with irregular contours (<a href=\"image.htm?imageKey=DERM%2F61822\" class=\"graphic graphic_picture graphicRef61822 \">picture 2</a>). Involvement most commonly occurs on the nose (rhinophyma) but may also be seen in other sites, such as the chin (gnathophyma), forehead (glabellophyma), and cheeks. Patients who develop this subtype of rosacea often have prominent sebaceous hyperplasia and very oily skin. The vast majority of patients with phymatous rosacea are adult men.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Papules and pustules</strong> &mdash; Rosacea can manifest with papules and pustules primarily localized to the central face (<a href=\"image.htm?imageKey=DERM%2F67890%7EDERM%2F53889%7EDERM%2F78747%7EDERM%2F63008\" class=\"graphic graphic_picture graphicRef67890 graphicRef53889 graphicRef78747 graphicRef63008 \">picture 1A-D</a>). Lesions may be mistaken for inflammatory acne vulgaris. Unlike acne vulgaris, comedones do not occur in rosacea, and inflammation may extend outward well beyond the follicular unit to form plaques. As an example, in occasional patients the whole nose may be tender, swollen, and red. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Flushing</strong> &mdash; This can be wet (accompanied by sweating) or dry and may be associated with subtle, transient, facial swelling. Examples of triggers for flushing are provided. (See <a href=\"#H432985\" class=\"local\">'Exacerbating factors'</a> below.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Telangiectasia</strong> &mdash; Telangiectasias are visible, enlarged, cutaneous blood vessels (<a href=\"image.htm?imageKey=DERM%2F71614\" class=\"graphic graphic_picture graphicRef71614 \">picture 4</a>). In rosacea, telangiectasias are predominantly located on the central face, especially on the cheeks.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ocular features</strong> &mdash; Ocular involvement occurs in more than 50 percent of patients with rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/48\" class=\"abstract_t\">48</a>]. Ocular rosacea may precede (20 percent), follow (50 percent), or occur concurrently with cutaneous disease [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>]. Both children and adults may be affected [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/12,49\" class=\"abstract_t\">12,49</a>]. Manifestations that strongly suggest rosacea include lid margin telangiectases, interpalpebral conjunctival injection, spade-shaped infiltrates on the cornea, scleritis, and sclerokeratitis (<a href=\"image.htm?imageKey=DERM%2F54397\" class=\"graphic graphic_picture graphicRef54397 \">picture 5</a>) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>]. Patients may also experience symptoms of burning, stinging, light sensitivity, and foreign body sensation and may develop chalazia, conjunctivitis, crusting on eyelashes, lid margin irregularity, and evaporative tear dysfunction [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/46\" class=\"abstract_t\">46</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Burning or stinging</strong> &mdash; Stinging or burning sensations in affected areas are common in patients with rosacea. Skin care products may irritate the skin and aggravate symptoms. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Edema</strong> &mdash; During or after an exacerbation of facial redness, facial edema can occur and may persist for days. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dry appearance of skin</strong> &mdash; A dry quality to the skin, manifesting as roughness and scaling, is often present.</p><p/><p class=\"headingAnchor\" id=\"H432985\"><span class=\"h1\">EXACERBATING FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple factors have been anecdotally associated with exacerbations of cutaneous signs and symptoms of rosacea, including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exposure to extremes of temperature</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sun exposure</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hot beverages</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Spicy foods</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Alcohol</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exercise</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Irritation from topical products </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psychologic feelings, especially anger, rage, and embarrassment</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Certain drugs such as nicotinic acid and vasodilators</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin barrier disruption </p><p/><p>In particular, an analysis of data reported by over 82,000 women in the Nurses' Health II Study found a slight increase in risk for a history of clinician-diagnosed rosacea among women with alcohol intake compared with women who denied use of alcohol [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/15\" class=\"abstract_t\">15</a>]. In the past, phymatous skin changes in rosacea were perceived by the lay public to be a consequence of heavy alcohol consumption. However, definitive evidence in support of an association between alcohol and increased risk for phymatous skin changes is lacking [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. </p><p class=\"headingAnchor\" id=\"H2193095500\"><span class=\"h1\">ASSOCIATED DISEASES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rosacea may be associated with increased risk for other diseases [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/50-52\" class=\"abstract_t\">50-52</a>]. Examples of reported associations include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A Danish nationwide cohort study that included over 49,475 patients with rosacea and over 4.3 million general population controls found modest associations between rosacea and several gastrointestinal diseases, including celiac disease (adjusted hazard ratio [aHR] 1.46, 95% CI 1.11-1.93), Crohn disease (aHR 1.45, 95% CI 1.19-1.77), ulcerative colitis (aHR 1.19, 95% CI 1.02-1.39), and irritable bowel syndrome (aHR 1.34, 95% CI 1.19-1.50) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/53\" class=\"abstract_t\">53</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An analysis of diagnostic data from 33,553 patients with rosacea and age- and sex-matched controls in the National Health Insurance Research Database in Taiwan found modest increases in risk for dyslipidemia (odds ratio [OR] 1.41, 95% CI 1.36-1.46), coronary artery disease (OR 1.35, 95% CI 1.29-1.41), and hypertension (OR 1.17, 95% CI 1.12-1.21) among patients with rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/54\" class=\"abstract_t\">54</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A review of data from 75,088 Caucasian women included in the Nurses' Health Study II found increased risk for thyroid cancer (OR 1.59, 95% CI 1.07-2.36) and basal cell carcinoma (OR 1.50, 95% CI 1.35-1.67) in women with a history of rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/55\" class=\"abstract_t\">55</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A Danish nationwide cohort study including all citizens older than 18 years, followed up from 1997 to 2011, found an increased risk for glioma in patients with rosacea (incidence rate ratio [IRR] 1.36, 95% CI 1.18-1.58) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/56\" class=\"abstract_t\">56</a>]. In a case-control study including nearly 7000 patients with rosacea and 34,000 matched controls from the same Danish cohort, patients with rosacea had an increased risk of autoimmune diseases, including type 1 diabetes mellitus, celiac disease, multiple sclerosis, and rheumatoid arthritis [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/57\" class=\"abstract_t\">57</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A slight increase in risk for any type of dementia or Alzheimer disease was detected among patients with rosacea in a Danish nationwide cohort that included over 82,439 patients with rosacea and over 5.5 million controls followed from 1997 to 2012 (aHR 1.07, 95% CI 1.01-1.14 and 1.25, 95% CI 1.14-1.37, respectively) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/58\" class=\"abstract_t\">58</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A case-control study of 65 patients with rosacea and matched controls found that patients with rosacea were more likely to report allergies, respiratory diseases, gastroesophageal reflux disease, other gastrointestinal diseases, hypertension, metabolic diseases, urogenital diseases, and female hormone imbalances [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/59\" class=\"abstract_t\">59</a>]. </p><p/><p>The reasons for the observed associations between rosacea and other diseases are unclear; a shared role for systemic inflammation is postulated for the association between rosacea and cardiovascular disease. Further study is necessary to confirm these associations and to determine whether patients with rosacea require increased screening for systemic diseases.</p><p class=\"headingAnchor\" id=\"H2005836\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinical assessment of the patient is usually sufficient for the diagnosis of rosacea. The diagnosis can be made based upon an assessment for diagnostic, major, and minor phenotypes. At least one diagnostic phenotype or two major phenotypes are required for diagnosis. </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Diagnostic phenotypes</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Fixed centrofacial erythema in a characteristic pattern that may periodically intensify</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Phymatous changes</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Major phenotypes</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Papules and pustules</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Flushing</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Telangiectasia</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Ocular manifestations (eg, lid margin telangiectases, interpalpebral conjunctival infection, spade-shaped infiltrates in the cornea, scleritis, sclerokeratitis)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Secondary phenotypes</strong></p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Burning or stinging</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Edema</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Dry appearance</p><p/><p>The cutaneous histopathologic findings in rosacea are nonspecific, and skin biopsies are rarely indicated. When the diagnosis is uncertain, biopsies may be performed to rule out other disorders or to provide support for a diagnosis of granulomatous rosacea. No serologic studies are useful for diagnosis.</p><p class=\"headingAnchor\" id=\"H394012187\"><span class=\"h2\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Specimens from erythematous facial skin exhibiting centrofacial erythema and telangiectasias usually show dilation of superficial blood vessels and a low-grade perivascular, lymphohistiocytic, inflammatory infiltrate with occasional plasma cells. Solar elastosis is often present.</p><p>Histopathologic examination of papular lesions usually reveals prominent perivascular and perifollicular inflammatory infiltrates in the superficial and mid-dermis composed of lymphocytes, neutrophils, and plasma cells. Superficial accumulations of neutrophils are present in pustules. In contrast to acne vulgaris, inflammation often is more perivascular and extends well beyond the follicle [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/60\" class=\"abstract_t\">60</a>]. <em>Demodex</em> mites are often detected in follicular orifices.</p><p>The histopathologic findings in skin exhibiting phymatous changes include sebaceous gland hyperplasia, follicular plugging, telangiectasias, pronounced dermal thickening and fibrosis, and large amounts of dermal mucin. Increased numbers of Factor XIIIa positive cells may be present in the dermis [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/61,62\" class=\"abstract_t\">61,62</a>].</p><p class=\"headingAnchor\" id=\"H1419957\"><span class=\"h2\">Referral to ophthalmology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients who have ocular symptoms or who are found to have visible signs suggestive of ocular involvement should be referred to ophthalmology for further evaluation.</p><p class=\"headingAnchor\" id=\"H394012195\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of skin conditions may present with clinical features that resemble rosacea. </p><p class=\"headingAnchor\" id=\"H654880239\"><span class=\"h2\">Centrofacial erythema</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Not all patients with red faces have rosacea. (See <a href=\"topic.htm?path=approach-to-the-patient-with-facial-erythema\" class=\"medical medical_review\">&quot;Approach to the patient with facial erythema&quot;</a>.) </p><p>The following conditions share features with centrofacial erythema of rosacea:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Ruddy complexion </strong>&ndash; Some fair-skinned patients, particularly those of Celtic origin, may have a naturally ruddy complexion to the skin. In contrast to the ruddy complexion, redness in rosacea primarily involves the central face.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Sun-damaged skin </strong>&ndash; Telangiectasia may occur as a manifestation of sun-damaged skin. Dyspigmentation and skin wrinkling are often also present. In contrast to rosacea, which primarily affects the central face, sun damage is often most evident on the lateral face and neck. The presence of other characteristics of rosacea, such as persistent facial erythema and frequent flushing, also support a diagnosis of rosacea. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Seborrheic dermatitis </strong>&ndash;<strong> </strong>Macular erythema and scale involving the perinasal area is a common finding in seborrheic dermatitis (<a href=\"image.htm?imageKey=DERM%2F56410\" class=\"graphic graphic_picture graphicRef56410 \">picture 6</a>). A greasy quality to the scale and involvement of other sites such as the scalp, retroauricular skin, and brow suggest this diagnosis. (See <a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">&quot;Seborrheic dermatitis in adolescents and adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acute cutaneous lupus erythematosus </strong>&ndash; The centrofacial redness in rosacea may be confused with malar erythema of systemic lupus erythematosus, particularly in patients who lack papulopustular lesions (<a href=\"image.htm?imageKey=DERM%2F75781%7EDERM%2F55875\" class=\"graphic graphic_picture graphicRef75781 graphicRef55875 \">picture 7A-B</a>). In acute cutaneous lupus erythematosus, the color of the skin has a violaceous quality and may show a more abrupt cutoff, especially at its most lateral margins (resembling a butterfly wing). </p><p/><p class=\"bulletIndent1\">Serologic testing for antinuclear antibodies in all patients with centrofacial erythema is <strong>not</strong> indicated. Patients should be clinically assessed for signs or symptoms of systemic lupus erythematosus; the need for laboratory work-up should be based upon the presence of mucocutaneous or systemic findings suggestive of this disorder. Skin biopsies of acute cutaneous lupus erythematosus usually (but not always) demonstrate interface dermatitis characterized by necrotic keratinocytes, intraepidermal lymphocytes, basal vacuolar degeneration, colloid bodies, and melanin incontinence. Although biopsies of rosacea may exhibit occasional intraepidermal lymphocytes and pyknotic keratinocytes, true interface dermatitis does not occur in rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/63\" class=\"abstract_t\">63</a>]. Differences in the likelihood of other pathologic findings have also been reported [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/63\" class=\"abstract_t\">63</a>]. (See <a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus#H3\" class=\"medical medical_review\">&quot;Overview of cutaneous lupus erythematosus&quot;, section on 'Acute cutaneous lupus erythematosus'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dermatomyositis </strong>&ndash; Dermatomyositis is an idiopathic inflammatory disorder that can affect skin and muscle tissue. Violaceous erythema involving the periorbital skin and central face can occur. The dusky, violaceous color of the facial eruption differs from the bright erythema that is typically seen in rosacea (<a href=\"image.htm?imageKey=DERM%2F56879\" class=\"graphic graphic_picture graphicRef56879 \">picture 8</a>). Examination for muscle weakness and other cutaneous signs of dermatomyositis is useful for diagnosis. Like acute cutaneous lupus erythematosus, skin biopsies reveal features of an interface dermatitis. (See <a href=\"topic.htm?path=clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults#H17269417\" class=\"medical medical_review\">&quot;Clinical manifestations of dermatomyositis and polymyositis in adults&quot;, section on 'Skin findings'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other flushing disorders </strong>&ndash; In addition to rosacea, facial flushing may occur in a wide variety of disorders. Examples include medication reactions, menopausal hot-flashes, neurologic disorders, carcinoid syndrome, mastocytosis, pheochromocytoma, medullary thyroid carcinoma, and serotonin syndrome. The possibility of such disorders should be considered in patients who present with flushing. (See <a href=\"topic.htm?path=approach-to-flushing-in-adults\" class=\"medical medical_review\">&quot;Approach to flushing in adults&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H158665310\"><span class=\"h2\">Papules and pustules</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The following papular and pustular disorders share features with rosacea:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acne vulgaris </strong>&ndash; Acne vulgaris is the most common skin disorder in the differential diagnosis of papulopustular rosacea. Individual inflammatory lesions of the two disorders may appear clinically identical. A key distinguishing feature between acne vulgaris and rosacea is the absence of comedones in rosacea (<a href=\"image.htm?imageKey=PC%2F68412\" class=\"graphic graphic_picture graphicRef68412 \">picture 9</a>). A prominent centrofacial distribution also suggests a diagnosis of rosacea. Acne vulgaris and rosacea coexist in some patients. (See <a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-acne-vulgaris\" class=\"medical medical_review\">&quot;Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Topical corticosteroid-induced acneiform eruptions </strong>&ndash; Topical corticosteroid use can result in the appearance of monomorphic inflammatory papules on facial skin. The patient history is valuable for diagnosis. Topical corticosteroids can also cause redness and burning skin sensations as a consequence of overuse. (See <a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use#H17\" class=\"medical medical_review\">&quot;General principles of dermatologic therapy and topical corticosteroid use&quot;, section on 'Cutaneous'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Perioral dermatitis </strong>&ndash; Perioral dermatitis presents with numerous small papules with fine scale in the perioral area (<a href=\"image.htm?imageKey=PC%2F73779%7EDERM%2F64577\" class=\"graphic graphic_picture graphicRef73779 graphicRef64577 \">picture 10A-B</a>). Sparing of the skin adjacent to the vermillion border of the lip is characteristic. Lesions may also occur in periorbital and perinasal distributions. In patients who have erroneously attempted to treat the eruption with topical corticosteroids, acneiform eruptions may also be present.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Keratosis pilaris rubra faceii </strong>&ndash; Persistent, rough, 1 to 2 mm follicularly-based papules on the face can occur as a manifestation of keratosis pilaris in children, adolescents, and young adults (<a href=\"image.htm?imageKey=DERM%2F77270\" class=\"graphic graphic_picture graphicRef77270 \">picture 11</a>). The condition presents with a rough, red, symmetrical, triangular patch of skin on each cheek that lacks papules or pustules. Typical keratosis pilaris also may be present on the backs of the arms and fronts of the thighs (<a href=\"image.htm?imageKey=DERM%2F60786%7EDERM%2F68488\" class=\"graphic graphic_picture graphicRef60786 graphicRef68488 \">picture 12A-B</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Demodicosis (</strong><strong><em>Demodex </em></strong><strong>folliculitis) </strong>&ndash;<strong> </strong>Demodicosis can present with numerous inflammatory papules on the face and is difficult to distinguish from papulopustular rosacea on clinical examination [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/64\" class=\"abstract_t\">64</a>]. Potassium hydroxide (KOH) preparation, skin surface sampling with cyanoacrylate adhesive (superglue) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/25\" class=\"abstract_t\">25</a>], or skin punch biopsy may demonstrate numerous <em>Demodex</em> mites. However, <em>Demodex</em> mites are also commonly detected in rosacea and in normal skin. Therefore, finding <em>Demodex</em> mites in a skin surface sample or skin biopsy specimen does not necessarily indicate demodicosis.</p><p/><p class=\"bulletIndent1\">Immunocompromised patients are at increased risk for this disorder. Multiple therapies have been reported to be effective for demodicosis in individual patients. Examples include topical <a href=\"topic.htm?path=permethrin-drug-information\" class=\"drug drug_general\">permethrin</a>, topical <a href=\"topic.htm?path=crotamiton-drug-information\" class=\"drug drug_general\">crotamiton</a>, oral <a href=\"topic.htm?path=ivermectin-drug-information\" class=\"drug drug_general\">ivermectin</a>, and topical or oral <a href=\"topic.htm?path=metronidazole-drug-information\" class=\"drug drug_general\">metronidazole</a> [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/64-68\" class=\"abstract_t\">64-68</a>]. (See <a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures#H4044416\" class=\"medical medical_review\">&quot;Office-based dermatologic diagnostic procedures&quot;, section on 'Potassium hydroxide preparation'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H2149662\"><span class=\"h1\">GRANULOMATOUS ROSACEA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The relationship of granulomatous rosacea to other presentations of rosacea has been debated, but in 2002, a committee of experts recognized this disorder as a possible variant of rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>]. Granulomatous rosacea presents with yellow-brown or monotonous, persisting, pink papules that are usually distributed on the cheeks and periorbital or perioral skin; background facial erythema and flushing are often absent. A granulomatous infiltrate is characteristically present on biopsy [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"abstract_t\">37</a>]. Granulomatous rosacea is characterized by the presence of epithelioid granulomas adjacent to hair follicles. Caseation is present in approximately 10 percent of cases [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/69\" class=\"abstract_t\">69</a>].</p><p>The features of granulomatous rosacea overlap with other disorders described in the literature that present with numerous, small, monomorphic facial papules and granulomatous infiltrates on biopsy. In adults, lupus miliaris disseminatus faciei, which presents with multiple red-brown 2 to 5 mm papules on the face and caseating granulomas on biopsy, has been reported [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/70-72\" class=\"abstract_t\">70-72</a>]. Rarely, B cell lymphomas and chronic lymphocytic leukemia present with facial cutaneous lesions that resemble granulomatous rosacea or phymatous skin changes of rosacea [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/73\" class=\"abstract_t\">73</a>]. </p><p>In addition, granulomatous facial dermatoses identified as childhood granulomatous periorificial dermatitis [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/74-76\" class=\"abstract_t\">74-76</a>] and facial Afro-Caribbean childhood eruption [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/77,78\" class=\"abstract_t\">77,78</a>] have been described in children. The status of these disorders as independent entities or forms of rosacea is unclear. </p><p class=\"headingAnchor\" id=\"H2149672\"><span class=\"h1\">PYODERMA FACIALE (ROSACEA FULMINANS)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The relationship of pyoderma faciale (also known as rosacea fulminans or rosacea conglobata) to rosacea also is uncertain [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"abstract_t\">45</a>]. Patients present with intensely inflammatory, purulent facial plaques and nodules with draining sinuses on a background of erythema (<a href=\"image.htm?imageKey=DERM%2F57401\" class=\"graphic graphic_picture graphicRef57401 \">picture 13</a>) [<a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/79,80\" class=\"abstract_t\">79,80</a>]. A history of rosacea may or may not be present. Young women are most commonly affected.</p><p class=\"headingAnchor\" id=\"H2149788\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rosacea is a common skin disorder that may occur in adults of all ethnic backgrounds, but is most commonly diagnosed in individuals with fair skin. Rarely, rosacea occurs in children. (See <a href=\"#H394012123\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pathogenesis of rosacea is poorly understood. Factors such as abnormalities in the innate immune system, inflammatory reactions to cutaneous microorganisms, ultraviolet radiation exposure, and vascular hyperreactivity have been identified as potential contributing factors. (See <a href=\"#H394012131\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Persistent centrofacial redness, phymatous skin changes, papules, pustules, flushing, telangiectases, burning or stinging sensations, cutaneous edema, and dryness are potential cutaneous manifestations of rosacea. Ocular abnormalities may also occur. (See <a href=\"#H432867\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In most patients, clinical assessment is sufficient for diagnosing rosacea and excluding other disorders that may resemble rosacea. Skin biopsies are rarely indicated, but can be useful in cases in which another disorder with specific histopathologic findings is suspected or for supporting a diagnosis of granulomatous rosacea. (See <a href=\"#H2005836\" class=\"local\">'Diagnosis'</a> above and <a href=\"#H394012195\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ocular involvement may present independently or in association with cutaneous manifestations of rosacea. Patients may exhibit features such as lid margin telangiectases, conjunctival injection, and ocular irritation. Patients with signs or symptoms of ocular rosacea should be referred to an ophthalmologist for further evaluation. (See <a href=\"#H1419957\" class=\"local\">'Referral to ophthalmology'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/1\" class=\"nounderline abstract_t\">Elewski BE, Draelos Z, Dr&eacute;no B, et al. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol 2011; 25:188.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/2\" class=\"nounderline abstract_t\">van Zuuren EJ, Kramer S, Carter B, et al. Interventions for rosacea. Cochrane Database Syst Rev 2011; :CD003262.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/3\" class=\"nounderline abstract_t\">Berg M. Epidemiological studies of the influence of sunlight on the skin. Photodermatol 1989; 6:80.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/4\" class=\"nounderline abstract_t\">McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol 2010; 63:33.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/5\" class=\"nounderline abstract_t\">Khaled A, Hammami H, Zeglaoui F, et al. Rosacea: 244 Tunisian cases. Tunis Med 2010; 88:597.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/6\" class=\"nounderline abstract_t\">Rosen T, Stone MS. Acne rosacea in blacks. J Am Acad Dermatol 1987; 17:70.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/7\" class=\"nounderline abstract_t\">Browning DJ, Rosenwasser G, Lugo M. Ocular rosacea in blacks. Am J Ophthalmol 1986; 101:441.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/8\" class=\"nounderline abstract_t\">Bae YI, Yun SJ, Lee JB, et al. Clinical evaluation of 168 korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype. Ann Dermatol 2009; 21:243.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/9\" class=\"nounderline abstract_t\">Alexis AF. Rosacea in patients with skin of color: uncommon but not rare. Cutis 2010; 86:60.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/10\" class=\"nounderline abstract_t\">Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol 1992; 26:590.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/11\" class=\"nounderline abstract_t\">Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010; 24:565.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/12\" class=\"nounderline abstract_t\">Chamaillard M, Mortemousque B, Boralevi F, et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol 2008; 144:167.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/13\" class=\"nounderline abstract_t\">Kroshinsky D, Glick SA. Pediatric rosacea. Dermatol Ther 2006; 19:196.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/14\" class=\"nounderline abstract_t\">Lacz NL, Schwartz RA. Rosacea in the pediatric population. Cutis 2004; 74:99.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/15\" class=\"nounderline abstract_t\">Li S, Cho E, Drucker AM, et al. Alcohol intake and risk of rosacea in US women. J Am Acad Dermatol 2017; 76:1061.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/16\" class=\"nounderline abstract_t\">Li S, Cho E, Drucker AM, et al. Obesity and risk for incident rosacea in US women. J Am Acad Dermatol 2017; 77:1083.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/17\" class=\"nounderline abstract_t\">Li S, Cho E, Drucker AM, et al. Cigarette Smoking and Risk of Incident Rosacea in Women. Am J Epidemiol 2017; 186:38.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/18\" class=\"nounderline abstract_t\">Mc Aleer MA, Lacey N, Powell FC. The pathophysiology of rosacea. G Ital Dermatol Venereol 2009; 144:663.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/19\" class=\"nounderline abstract_t\">Dahl MV. Pathogenesis of rosacea. Adv Dermatol 2001; 17:29.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/20\" class=\"nounderline abstract_t\">Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci 2009; 55:77.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/21\" class=\"nounderline abstract_t\">Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13:975.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/22\" class=\"nounderline abstract_t\">Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 2011; 131:688.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/23\" class=\"nounderline abstract_t\">Zhao YE, Wu LP, Peng Y, Cheng H. Retrospective analysis of the association between Demodex infestation and rosacea. Arch Dermatol 2010; 146:896.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/24\" class=\"nounderline abstract_t\">Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28:443.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/25\" class=\"nounderline abstract_t\">Forton F, Seys B. Density of Demodex folliculorum in rosacea: a case-control study using standardized skin-surface biopsy. Br J Dermatol 1993; 128:650.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/26\" class=\"nounderline abstract_t\">Erba&#287;ci Z, Ozg&ouml;zta&#351;i O. The significance of Demodex folliculorum density in rosacea. Int J Dermatol 1998; 37:421.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/27\" class=\"nounderline abstract_t\">Lacey N, Delaney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007; 157:474.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/28\" class=\"nounderline abstract_t\">Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol 2013; 69:S27.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/29\" class=\"nounderline abstract_t\">J&oslash;rgensen AR, Egeberg A, Gideonsson R, et al. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2017; 31:2010.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/30\" class=\"nounderline abstract_t\">Whitfeld M, Gunasingam N, Leow LJ, et al. Staphylococcus epidermidis: a possible role in the pustules of rosacea. J Am Acad Dermatol 2011; 64:49.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/31\" class=\"nounderline abstract_t\">Dahl MV, Ross AJ, Schlievert PM. Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol 2004; 50:266.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/32\" class=\"nounderline abstract_t\">Fernandez-Obregon A, Patton DL. The role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin. Cutis 2007; 79:163.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/33\" class=\"nounderline abstract_t\">Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 2008; 6:759.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/34\" class=\"nounderline abstract_t\">Brauchle M, Funk JO, Kind P, Werner S. Ultraviolet B and H2O2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1996; 271:21793.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/35\" class=\"nounderline abstract_t\">Bielenberg DR, Bucana CD, Sanchez R, et al. Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 1998; 111:864.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/36\" class=\"nounderline abstract_t\">Longuet-Perret I, Schmitt D, Viac J. Tumour necrosis factor-alpha is involved in the contrasting effects of ultraviolet B and ultraviolet A1 radiation on the release by normal human keratinocytes of vascular permeability factor. Br J Dermatol 1998; 138:221.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/37\" class=\"nounderline abstract_t\">Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51:327.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/38\" class=\"nounderline abstract_t\">Guzman-Sanchez DA, Ishiuji Y, Patel T, et al. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 2007; 57:800.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/39\" class=\"nounderline abstract_t\">Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation. J Investig Dermatol Symp Proc 2011; 15:33.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/40\" class=\"nounderline abstract_t\">Spoendlin J, Voegel JJ, Jick SS, Meier CR. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom. J Am Acad Dermatol 2013; 69:399.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/41\" class=\"nounderline abstract_t\">Berg M, Lid&eacute;n S. An epidemiological study of rosacea. Acta Derm Venereol 1989; 69:419.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/42\" class=\"nounderline abstract_t\">Berg M, Lid&eacute;n S. Postmenopausal female rosacea patients are more disposed to react with migraine. Dermatology 1996; 193:73.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/43\" class=\"nounderline abstract_t\">Ramelet AA. Rosacea: a reaction pattern associated with ocular lesions and migraine? Arch Dermatol 1994; 130:1448.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/44\" class=\"nounderline abstract_t\">Tan SG, Cunliffe WJ. Rosacea and migraine. Br Med J 1976; 1:21.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/45\" class=\"nounderline abstract_t\">Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 46:584.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/46\" class=\"nounderline abstract_t\">Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018; 78:148.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/47\" class=\"nounderline abstract_t\">Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol 2017; 176:431.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/48\" class=\"nounderline abstract_t\">Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003; 22:230.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/49\" class=\"nounderline abstract_t\">Nazir SA, Murphy S, Siatkowski RM, et al. Ocular rosacea in childhood. Am J Ophthalmol 2004; 137:138.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/50\" class=\"nounderline abstract_t\">Haber R, El Gemayel M. Comorbidities in rosacea: A systematic review and update. J Am Acad Dermatol 2018; 78:786.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/51\" class=\"nounderline abstract_t\">Gallo RL, Granstein RD, Kang S, et al. Rosacea comorbidities and future research: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol 2018; 78:167.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/52\" class=\"nounderline abstract_t\">Holmes AD, Spoendlin J, Chien AL, et al. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol 2018; 78:156.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/53\" class=\"nounderline abstract_t\">Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol 2017; 176:100.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/54\" class=\"nounderline abstract_t\">Hua TC, Chung PI, Chen YJ, et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J Am Acad Dermatol 2015; 73:249.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/55\" class=\"nounderline abstract_t\">Li WQ, Zhang M, Danby FW, et al. Personal history of rosacea and risk of incident cancer among women in the US. Br J Cancer 2015; 113:520.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/56\" class=\"nounderline abstract_t\">Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Association of Rosacea With Risk for Glioma in a Danish Nationwide Cohort Study. JAMA Dermatol 2016; 152:541.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/57\" class=\"nounderline abstract_t\">Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol 2016; 74:667.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/58\" class=\"nounderline abstract_t\">Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Patients with rosacea have increased risk of dementia. Ann Neurol 2016; 79:921.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/59\" class=\"nounderline abstract_t\">Rainer BM, Fischer AH, Luz Felipe da Silva D, et al. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol 2015; 73:604.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/60\" class=\"nounderline abstract_t\">Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol 1969; 100:683.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/61\" class=\"nounderline abstract_t\">Tope WD, Sangueza OP. Rhinophyma's fibrous variant. Histopathology and immunohistochemistry. Am J Dermatopathol 1994; 16:307.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/62\" class=\"nounderline abstract_t\">Aloi F, Tomasini C, Soro E, Pippione M. The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol 2000; 42:468.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/63\" class=\"nounderline abstract_t\">Brown TT, Choi EY, Thomas DG, et al. Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells. J Am Acad Dermatol 2014; 71:100.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/64\" class=\"nounderline abstract_t\">Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol 2009; 60:453.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/65\" class=\"nounderline abstract_t\">Baima B, Sticherling M. Demodicidosis revisited. Acta Derm Venereol 2002; 82:3.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/66\" class=\"nounderline abstract_t\">Karincaoglu Y, Miman O, Kalayci B, et al. A demodicosis case which responded to systemic ivermectin. Eur J Dermatol 2009; 19:189.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/67\" class=\"nounderline abstract_t\">Forstinger C, Kittler H, Binder M. Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream. J Am Acad Dermatol 1999; 41:775.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/68\" class=\"nounderline abstract_t\">Aquilina C, Viraben R, Sire S. Ivermectin-responsive Demodex infestation during human immunodeficiency virus infection. A case report and literature review. Dermatology 2002; 205:394.</a></li><li class=\"breakAll\">Ioffreda MD. Inflammatory diseases of the hair follicles, sweat glands, and cartilage. In: Lever's Histopathology of the Skin, 9th ed, Elder D, Elenitsas R, Johnson BL, et al. (Eds), Lippincott Williams and Wilkins, Philadelphia 2005. p.469.</li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/70\" class=\"nounderline abstract_t\">Al-Mutairi N. Nosology and therapeutic options for lupus miliaris disseminatus faciei. J Dermatol 2011; 38:864.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/71\" class=\"nounderline abstract_t\">Esteves T, Faria A, Alves R, et al. Lupus miliaris disseminatus faciei: a case report. Dermatol Online J 2010; 16:10.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/72\" class=\"nounderline abstract_t\">van de Scheur MR, van der Waal RI, Starink TM. Lupus miliaris disseminatus faciei: a distinctive rosacea-like syndrome and not a granulomatous form of rosacea. Dermatology 2003; 206:120.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/73\" class=\"nounderline abstract_t\">Barzilai A, Feuerman H, Quaglino P, et al. Cutaneous B-cell neoplasms mimicking granulomatous rosacea or rhinophyma. Arch Dermatol 2012; 148:824.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/74\" class=\"nounderline abstract_t\">Lucas CR, Korman NJ, Gilliam AC. Granulomatous periorificial dermatitis: a variant of granulomatous rosacea in children? J Cutan Med Surg 2009; 13:115.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/75\" class=\"nounderline abstract_t\">Zalaudek I, Di Stefani A, Ferrara G, Argenziano G. Childhood granulomatous periorificial dermatitis: a controversial disease. J Dtsch Dermatol Ges 2005; 3:252.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/76\" class=\"nounderline abstract_t\">Knautz MA, Lesher JL Jr. Childhood granulomatous periorificial dermatitis. Pediatr Dermatol 1996; 13:131.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/77\" class=\"nounderline abstract_t\">Williams HC, Ashworth J, Pembroke AC, Breathnach SM. FACE--facial Afro-Caribbean childhood eruption. Clin Exp Dermatol 1990; 15:163.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/78\" class=\"nounderline abstract_t\">Cribier B, Lieber-Mbomeyo A, Lipsker D. [Clinical and histological study of a case of facial Afro-Caribbean childhood eruption (FACE)]. Ann Dermatol Venereol 2008; 135:663.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/79\" class=\"nounderline abstract_t\">Plewig G, Jansen T, Kligman AM. Pyoderma faciale. A review and report of 20 additional cases: is it rosacea? Arch Dermatol 1992; 128:1611.</a></li><li><a href=\"https://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis/abstract/80\" class=\"nounderline abstract_t\">Ormond P, Rogers S. Case 3. Pyoderma faciale (PF) (rosacea fulminans). Clin Exp Dermatol 2003; 28:107.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 13621 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2149788\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H394012116\" id=\"outline-link-H394012116\">INTRODUCTION</a></li><li><a href=\"#H394012123\" id=\"outline-link-H394012123\">EPIDEMIOLOGY</a></li><li><a href=\"#H394012131\" id=\"outline-link-H394012131\">PATHOGENESIS</a><ul><li><a href=\"#H433190\" id=\"outline-link-H433190\">Immune dysfunction</a></li><li><a href=\"#H433233\" id=\"outline-link-H433233\">Microorganisms</a><ul><li><a href=\"#H433276\" id=\"outline-link-H433276\">- Demodex</a></li><li><a href=\"#H433283\" id=\"outline-link-H433283\">- Bacillus olenorium</a></li><li><a href=\"#H433290\" id=\"outline-link-H433290\">- Helicobacter pylori</a></li><li><a href=\"#H433297\" id=\"outline-link-H433297\">- Other</a></li></ul></li><li><a href=\"#H433400\" id=\"outline-link-H433400\">Ultraviolet radiation</a></li><li><a href=\"#H433473\" id=\"outline-link-H433473\">Vascular hyperreactivity</a></li><li><a href=\"#H433494\" id=\"outline-link-H433494\">Genetics</a></li></ul></li><li><a href=\"#H811056387\" id=\"outline-link-H811056387\">CLASSIFICATION</a></li><li><a href=\"#H432867\" id=\"outline-link-H432867\">CLINICAL FEATURES</a></li><li><a href=\"#H432985\" id=\"outline-link-H432985\">EXACERBATING FACTORS</a></li><li><a href=\"#H2193095500\" id=\"outline-link-H2193095500\">ASSOCIATED DISEASES</a></li><li><a href=\"#H2005836\" id=\"outline-link-H2005836\">DIAGNOSIS</a><ul><li><a href=\"#H394012187\" id=\"outline-link-H394012187\">Histopathology</a></li><li><a href=\"#H1419957\" id=\"outline-link-H1419957\">Referral to ophthalmology</a></li></ul></li><li><a href=\"#H394012195\" id=\"outline-link-H394012195\">DIFFERENTIAL DIAGNOSIS</a><ul><li><a href=\"#H654880239\" id=\"outline-link-H654880239\">Centrofacial erythema</a></li><li><a href=\"#H158665310\" id=\"outline-link-H158665310\">Papules and pustules</a></li></ul></li><li><a href=\"#H2149662\" id=\"outline-link-H2149662\">GRANULOMATOUS ROSACEA</a></li><li><a href=\"#H2149672\" id=\"outline-link-H2149672\">PYODERMA FACIALE (ROSACEA FULMINANS)</a></li><li><a href=\"#H2149788\" id=\"outline-link-H2149788\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/13621|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/53889\" class=\"graphic graphic_picture\">- Rosacea papules on face</a></li><li><a href=\"image.htm?imageKey=DERM/63008\" class=\"graphic graphic_picture\">- Rosacea in dark skin</a></li><li><a href=\"image.htm?imageKey=DERM/61822\" class=\"graphic graphic_picture\">- Rosacea rhinophyma</a></li><li><a href=\"image.htm?imageKey=DERM/77020\" class=\"graphic graphic_picture\">- Rosacea erythema</a></li><li><a href=\"image.htm?imageKey=DERM/56083\" class=\"graphic graphic_picture\">- Rosacea erythema cheek</a></li><li><a href=\"image.htm?imageKey=DERM/67890\" class=\"graphic graphic_picture\">- Rosacea papules</a></li><li><a href=\"image.htm?imageKey=DERM/78747\" class=\"graphic graphic_picture\">- Rosacea papules and pustules</a></li><li><a href=\"image.htm?imageKey=DERM/71614\" class=\"graphic graphic_picture\">- Telangiectasia nose</a></li><li><a href=\"image.htm?imageKey=DERM/54397\" class=\"graphic graphic_picture\">- Ocular rosacea telangiectasias</a></li><li><a href=\"image.htm?imageKey=DERM/56410\" class=\"graphic graphic_picture\">- Seborrheic dermatitis face</a></li><li><a href=\"image.htm?imageKey=DERM/75781\" class=\"graphic graphic_picture\">- Acute cutaneous lupus erythematosus - malar</a></li><li><a href=\"image.htm?imageKey=DERM/55875\" class=\"graphic graphic_picture\">- Acute cutaneous lupus erythematosus - malar eruption</a></li><li><a href=\"image.htm?imageKey=DERM/56879\" class=\"graphic graphic_picture\">- Dermatomyositis - heliotrope eruption</a></li><li><a href=\"image.htm?imageKey=PC/68412\" class=\"graphic graphic_picture\">- Acne mixed type</a></li><li><a href=\"image.htm?imageKey=PC/73779\" class=\"graphic graphic_picture\">- Perioral dermatitis</a></li><li><a href=\"image.htm?imageKey=DERM/64577\" class=\"graphic graphic_picture\">- Perioral dermatitis lesions</a></li><li><a href=\"image.htm?imageKey=DERM/77270\" class=\"graphic graphic_picture\">- Keratosis pilaris rubra faciei</a></li><li><a href=\"image.htm?imageKey=DERM/60786\" class=\"graphic graphic_picture\">- Keratosis pilaris light skin</a></li><li><a href=\"image.htm?imageKey=DERM/68488\" class=\"graphic graphic_picture\">- Keratosis pilaris dark skin</a></li><li><a href=\"image.htm?imageKey=DERM/57401\" class=\"graphic graphic_picture\">- Pyoderma faciale</a></li></ul></li><li><div id=\"DERM/13621|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PC/60541\" class=\"graphic graphic_table\">- Fitzpatrick skin phototypes</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-flushing-in-adults\" class=\"medical medical_review\">Approach to flushing in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-facial-erythema\" class=\"medical medical_review\">Approach to the patient with facial erythema</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">Clinical manifestations of dermatomyositis and polymyositis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use\" class=\"medical medical_review\">General principles of dermatologic therapy and topical corticosteroid use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-rosacea\" class=\"medical medical_review\">Management of rosacea</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=office-based-dermatologic-diagnostic-procedures\" class=\"medical medical_review\">Office-based dermatologic diagnostic procedures</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cutaneous-lupus-erythematosus\" class=\"medical medical_review\">Overview of cutaneous lupus erythematosus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-manifestations-and-diagnosis-of-acne-vulgaris\" class=\"medical medical_review\">Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">Seborrheic dermatitis in adolescents and adults</a></li></ul></div></div>","javascript":null}